Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Mavromoustakos

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
Steroids|January 20, 2021
Organotin derivatives of cholic acid induce apoptosis into breast cancer cells and interfere with mitochondrion; Synthesis, characterization and biological evaluationM E K Stathopoulou, N Zoupanou, C N Banti, et al.
Biochimica Et Biophysica Acta|March 20, 2013
Interactions of the potent synthetic AT1 antagonist analog BV6 with membrane bilayers and mesoporous silicate matricesG Agelis, A Resvani, D Ntountaniotis, et al.
Biochimica Et Biophysica Acta|November 21, 2009
Interactions at the bilayer interface and receptor site induced by the novel synthetic pyrrolidinone analog MMK3C Fotakis, S Gega, E Siapi, et al.
Antibiotics (Basel, Switzerland)|November 10, 2019
An Efficient Disinfectant, Composite Material {SLS@[Zn<sub>3</sub>(CitH)<sub>2</sub>]} as Ingredient for Development of Sterilized and Non Infectious Contact LensV A Karetsi, C N Banti, N Kourkoumelis, et al.
Bioorganic & Medicinal Chemistry|June 16, 2001
Synthesis and study of a cyclic angiotensin II antagonist analogue reveals the role of pi*--pi* interactions in the C-terminal aromatic residue for agonist activity and its structure resemblance with AT(1) non-peptide antagonistsL Polevaya, T Mavromoustakos, P Zoumboulakis, et al.
Current Topics in Medicinal Chemistry|February 18, 2004
Conformation and bioactivity. Design and discovery of novel antihypertensive drugsT Mavromoustakos, M Zervou, P Zoumpoulakis, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Steroids|January 20, 2021
Organotin derivatives of cholic acid induce apoptosis into breast cancer cells and interfere with mitochondrion; Synthesis, characterization and biological evaluationM E K Stathopoulou, N Zoupanou, C N Banti, et al.
Biochimica Et Biophysica Acta|March 20, 2013
Interactions of the potent synthetic AT1 antagonist analog BV6 with membrane bilayers and mesoporous silicate matricesG Agelis, A Resvani, D Ntountaniotis, et al.
Biochimica Et Biophysica Acta|November 21, 2009
Interactions at the bilayer interface and receptor site induced by the novel synthetic pyrrolidinone analog MMK3C Fotakis, S Gega, E Siapi, et al.
Antibiotics (Basel, Switzerland)|November 10, 2019
An Efficient Disinfectant, Composite Material {SLS@[Zn<sub>3</sub>(CitH)<sub>2</sub>]} as Ingredient for Development of Sterilized and Non Infectious Contact LensV A Karetsi, C N Banti, N Kourkoumelis, et al.
Bioorganic & Medicinal Chemistry|June 16, 2001
Synthesis and study of a cyclic angiotensin II antagonist analogue reveals the role of pi*--pi* interactions in the C-terminal aromatic residue for agonist activity and its structure resemblance with AT(1) non-peptide antagonistsL Polevaya, T Mavromoustakos, P Zoumboulakis, et al.
Current Topics in Medicinal Chemistry|February 18, 2004
Conformation and bioactivity. Design and discovery of novel antihypertensive drugsT Mavromoustakos, M Zervou, P Zoumpoulakis, et al.
Pageof 8